Metraipolis › archive › dc_fec16fc94240

Activation of TP53 target genes in the primary response of triple-negative breast cancer cells to doxorubicin treatment — Europe PMC PMID:41345520

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41345520
DOI
10.1038/s41598-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-07T22:28:22.399Z
SHA-256 of the archived text
6884dc4ee923a393c9ba7c6567eede85317aea326e6c3c453a0ea1d4495f181c
Stable URL of this page
https://metraipolis.com/documento/dc_fec16fc94240

How to cite

Activation of TP53 target genes in the primary response of triple-negative breast cancer cells to doxorubicin treatment — Europe PMC PMID:41345520 — Europe PMC (en), https://europepmc.org/article/MED/41345520 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fec16fc94240 (Metraipolis archive dc_fec16fc94240, sha256 6884dc4ee923a393c9ba7c6567eede85317aea326e6c3c453a0ea1d4495f181c)
BibTeX
@misc{dcfec16fc94240,
  title = {Activation of TP53 target genes in the primary response of triple-negative breast cancer cells to doxorubicin treatment — Europe PMC PMID:41345520},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41345520},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fec16fc94240; sha256 6884dc4ee923a393c9ba7c6567eede85317aea326e6c3c453a0ea1d4495f181c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41345520. Agents can read the archived copy with the MCP tool read_document.